Sign In
Free Newsletter
May 25, 2017
Reforming FDA, not price control, is path to cheaper drugs
It is easy to see the political allure of “cheap drugs,” but what is often ignored by advocates of market distorting price controls is the long-term impact such policies will have on medical innovation and access.
